Lund, Sweden

Johan Evenäs

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Johan Evenäs: Innovator in Pharmaceutical Chemistry**

Introduction

Johan Evenäs, an accomplished inventor and researcher based in Lund, Sweden, has made significant contributions to the field of pharmaceutical chemistry. With a portfolio of three patents, his work primarily focuses on developing innovative compounds that target inflammatory and hyperproliferative disorders. His expertise and dedication to research have positioned him as a notable figure in the industry.

Latest Patents

Two of Johan Evenäs’ latest patents include groundbreaking 2-oxothiatole compounds that have shown potential as cPLA2 inhibitors. These compounds are tailored for treating inflammatory disorders and hyperproliferative disorders. The compounds are characterized by complex chemical structures that include various functional groups, showcasing his depth of knowledge in chemical synthesis and medicinal chemistry. The detailed formulations provide pathways for new therapeutic options in treating prevalent medical conditions.

Career Highlights

Throughout his career, Johan has been associated with prominent companies, including Avexxin AB and Apoglyx AB. His roles within these organizations have allowed him to collaborate on critical research projects, leading to his notable achievements in developing new pharmaceutical compounds. His work exemplifies the synergy between innovative thinking and practical application in the biotech sector.

Collaborations

Johan Evenäs has collaborated with esteemed colleagues, including Thomas Brimert and Berit Johansen. Together, they have explored novel approaches to drug development, enhancing the therapeutic landscape for various diseases. These collaborations reflect his commitment to teamwork and shared knowledge in the scientific community.

Conclusion

Johan Evenäs stands out as a distinguished inventor with a clear focus on addressing significant health challenges through innovation. His patented compounds represent a leap forward in treatment options for inflammatory and hyperproliferative disorders, underscoring the importance of research and collaboration in advancing pharmaceutical science. With his continued efforts, he is sure to leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…